Skip to main content
. Author manuscript; available in PMC: 2021 Oct 23.
Published in final edited form as: Clin Infect Dis. 2020 Oct 23;71(7):1604–1612. doi: 10.1093/cid/ciz1049

Table 5. Associations of Outcomes of Hospitalized Patients With Culture-positive Pneumonia With Source(s) of Positive Cultures, Adjusted for Demographics, Baseline Comorbidities, and Illness Severity.

Outcome Respiratory vs Blood Both vs Blood Both vs Respiratory
Case fatality 0.93 (.81–1.06) 1.47 (1.12–1.94) 1.59 (1.22–2.08)
30-day readmission 1.16 (.97–1.39) 1.12 (.71–1.78) 0.97 (.61–1.53)
Late ICUa 0.98 (.81–1.17) 0.95 (.53–1.70) 0.97 (.54–1.75)
Late IMVa 1.52 (1.28–1.81) 1.64 (1.11–2.42) 1.08 (.72–1.60)
Late vasopressora 0.78 (.67–.92) 1.02 (.70–1.49) 1.31 (.90–1.90)
Mean multiplier
  Length of stay 0.90 (.87–.93) 1.06 (.96–1.17) 1.18 (1.07–1.29)
  Costs 0.87 (.82–.92) 1.08 (.97–1.20) 1.24 (1.14–1.35)

Data are presented as odds ratio or multiplier (95% confidence interval). Abbreviations: ICU, intensive care unit; IMV, invasive mechanical ventilation.

a

Among patients not previously in ICU, on IMV, or vasopressor, respectively.